0HMP.L - Bellerophon Therapeutics, Inc.
| Previous close | 6.94 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 3,958 |
| Market cap | N/A |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.88 |
| Earnings date | 14 Aug 2023 - 18 Aug 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Bellerophon Therapeutics (NASDAQ:BLPH) delivers shareholders fantastic 978% return over 1 year, surging 18% in the last week alone
Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit...
ZacksBellerophon Therapeutics (BLPH) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Bellerophon Therapeutics (BLPH) closed at $7.65, marking a +1.06% move from the previous day.
ZacksBellerophon (BLPH) to Report Q1 Earnings: What's in the Cards?
Bellerophon (BLPH) is expected to provide updates on its proprietary INOpulse platform, being developed for treating several pulmonary hypertension indications, on its first-quarter earnings call.
ZacksBellerophon Therapeutics (BLPH) Stock Sinks As Market Gains: What You Should Know
Bellerophon Therapeutics (BLPH) closed at $10.04 in the latest trading session, marking a -0.4% move from the prior day.
ZacksBellerophon Therapeutics (BLPH) Dips More Than Broader Markets: What You Should Know
Bellerophon Therapeutics (BLPH) closed the most recent trading day at $9.92, moving -0.6% from the previous trading session.
ZacksZacks.com featured highlights Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus
Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus have been highlighted in this Screen of The Week article.
- Simply Wall St.
When Will Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Turn A Profit?
We feel now is a pretty good time to analyse Bellerophon Therapeutics, Inc.'s ( NASDAQ:BLPH ) business as it appears...
ZacksBellerophon Therapeutics (BLPH) Is a Great Choice for 'Trend' Investors, Here's Why
Bellerophon Therapeutics (BLPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
ZacksHere's Why Momentum in Bellerophon Therapeutics (BLPH) Should Keep going
Bellerophon Therapeutics (BLPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
- Simply Wall St.
Companies Like Bellerophon Therapeutics (NASDAQ:BLPH) Could Be Quite Risky
Just because a business does not make any money, does not mean that the stock will go down. For example, although...